Nifty
Sensex
:
:
11873.05
40431.60
110.60 (0.94%)
448.62 (1.12%)

Pharmaceuticals & Drugs

Rating :
57/99  (View)

BSE: 524824 | NSE: BALPHARMA

68.35
-2.60 (-3.66%)
19-Oct-2020 | 3:55PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  71.80
  •  73.60
  •  67.15
  •  70.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  213422
  •  145.87
  •  73.60
  •  23.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 100.27
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 215.59
  • N/A
  • 1.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.45%
  • 1.26%
  • 38.70%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 17.59%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.12
  • -2.91
  • -6.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.56
  • -19.45
  • -21.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.00
  • 40.50
  • 34.79

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.51
  • 1.75
  • 1.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.67
  • 12.73
  • 12.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
52
49
6%
34
55
-39%
43
54
-19%
45
57
-22%
Expenses
47
48
-1%
33
49
-32%
42
50
-15%
43
53
-19%
EBITDA
5
2
219%
1
6
-90%
1
4
-82%
2
4
-56%
EBIDTM
10%
3%
2%
11%
2%
7%
4%
7%
Other Income
0
0
-30%
1
-1
-
0
1
-46%
0
0
-50%
Interest
3
3
-15%
3
4
-17%
3
3
6%
3
3
6%
Depreciation
2
1
42%
4
2
51%
1
1
-1%
1
1
16%
PBT
1
-3
-
-5
-1
-
-3
1
-
-3
0
-
Tax
0
0
-
0
-2
-
1
-1
-
-1
1
-
PAT
0
-2
-
-5
1
-
-4
2
-
-2
-1
-
PATM
1%
-5%
-14%
2%
-9%
3%
-4%
-1%
EPS
0.20
-1.73
-
-3.34
0.77
-
-2.61
1.12
-
-1.40
-0.53
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Net Sales
174
171
225
209
229
198
187
179
114
106
104
Net Sales Growth
-19%
-24%
8%
-9%
15%
6%
5%
57%
8%
3%
 
Cost Of Goods Sold
88
75
104
89
104
94
87
84
55
55
48
Gross Profit
86
96
121
121
125
104
100
95
60
51
55
GP Margin
50%
56%
54%
58%
55%
53%
53%
53%
52%
48%
53%
Total Expenditure
166
166
207
192
214
183
170
161
104
101
93
Power & Fuel Cost
-
5
6
6
6
5
5
4
3
2
2
% Of Sales
-
3%
3%
3%
3%
2%
2%
2%
3%
2%
2%
Employee Cost
-
50
50
52
45
37
32
28
21
20
20
% Of Sales
-
29%
22%
25%
20%
19%
17%
16%
18%
19%
20%
Manufacturing Exp.
-
16
20
18
21
20
21
18
11
9
8
% Of Sales
-
9%
9%
9%
9%
10%
11%
10%
10%
8%
8%
General & Admin Exp.
-
7
10
11
17
14
12
12
5
5
4
% Of Sales
-
4%
4%
5%
7%
7%
7%
6%
5%
4%
4%
Selling & Distn. Exp.
-
11
16
16
20
13
12
13
9
10
9
% Of Sales
-
6%
7%
7%
9%
7%
6%
8%
8%
9%
9%
Miscellaneous Exp.
-
1
1
0
1
0
1
1
1
1
9
% Of Sales
-
1%
0%
0%
0%
0%
0%
1%
1%
1%
1%
EBITDA
8
5
18
17
15
15
17
18
10
5
11
EBITDA Margin
5%
3%
8%
8%
6%
7%
9%
10%
9%
5%
10%
Other Income
2
2
1
2
3
1
1
1
1
3
0
Interest
12
13
13
9
8
6
7
7
7
6
5
Depreciation
8
8
6
7
6
7
7
5
3
3
2
PBT
-10
-14
0
3
3
3
5
7
1
-1
4
Tax
0
-1
-2
3
3
2
1
2
1
1
1
Tax Rate
0%
5%
1,180%
87%
114%
90%
25%
23%
61%
-57%
26%
PAT
-10
-12
4
3
2
1
4
5
0
-1
3
PAT before Minority Interest
-10
-13
2
0
0
0
4
5
0
-1
3
Minority Interest
0
1
2
2
2
1
0
0
0
0
0
PAT Margin
-6%
-7%
2%
1%
1%
1%
2%
3%
0%
-1%
3%
PAT Growth
0%
-422%
36%
59%
24%
-61%
-29%
1,137%
129%
-148%
 
EPS
-7.15
-8.61
2.67
1.96
1.23
0.99
2.55
3.57
0.29
-1.01
2.11

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Shareholder's Funds
52
67
65
62
55
55
50
36
36
37
Share Capital
14
14
14
14
13
13
11
10
10
10
Total Reserves
38
52
51
48
40
40
37
26
25
27
Non-Current Liabilities
34
38
46
30
45
16
18
65
61
53
Secured Loans
23
28
33
13
15
6
7
54
54
46
Unsecured Loans
0
1
1
5
20
1
1
4
0
1
Long Term Provisions
4
3
2
3
2
2
1
0
0
0
Current Liabilities
159
163
154
143
111
92
87
35
28
31
Trade Payables
39
47
50
54
47
39
34
27
22
23
Other Current Liabilities
31
28
34
16
12
12
9
6
5
6
Short Term Borrowings
90
87
68
71
50
40
43
0
0
0
Short Term Provisions
0
1
2
1
2
2
2
2
1
2
Total Liabilities
238
261
260
233
211
164
155
135
124
122
Net Block
71
70
71
60
56
52
55
54
55
55
Gross Block
98
90
85
66
106
95
90
77
74
67
Accumulated Depreciation
27
19
13
6
50
43
35
23
19
13
Non Current Assets
77
79
75
69
68
59
60
54
55
55
Capital Work in Progress
3
4
0
2
4
1
0
0
0
0
Non Current Investment
0
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
2
3
3
7
8
5
4
0
0
0
Other Non Current Assets
2
3
1
0
0
0
0
0
0
0
Current Assets
161
182
185
165
143
105
95
81
69
61
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
68
70
66
55
42
36
32
32
29
24
Sundry Debtors
50
65
64
62
57
45
45
37
32
29
Cash & Bank
3
4
4
5
5
5
3
2
2
1
Other Current Assets
41
1
0
1
40
19
15
9
7
7
Short Term Loans & Adv.
40
42
50
42
38
17
14
6
5
4
Net Current Assets
2
19
30
21
32
13
8
46
41
30
Total Assets
238
261
260
233
211
164
155
135
124
122

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
23
8
1
6
-19
15
13
5
-5
13
PBT
-14
0
3
3
3
5
7
1
-1
4
Adjustment
19
17
15
15
11
12
10
9
7
7
Changes in Working Capital
18
-7
-16
-10
-33
-1
-3
-6
-11
3
Cash after chg. in Working capital
23
10
2
8
-19
16
14
4
-4
14
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
0
-2
-1
-1
-1
-1
-1
0
-1
-1
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-5
-8
-4
-8
-14
-5
-7
-2
5
-11
Net Fixed Assets
-6
-5
-4
42
-13
-5
-16
-3
-6
-11
Net Investments
0
0
-7
1
0
-1
0
0
0
0
Others
1
-3
8
-51
-1
1
8
1
11
0
Cash from Financing Activity
-20
0
4
-6
32
-7
-8
-2
1
-3
Net Cash Inflow / Outflow
-2
0
1
-8
-1
2
-2
1
0
-1
Opening Cash & Equivalents
2
3
2
-18
5
3
5
2
1
3
Closing Cash & Equivalent
1
2
3
-25
5
5
3
2
2
1

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
37
47
46
44
41
41
43
34
34
31
ROA
-5%
1%
0%
0%
0%
2%
4%
0%
-1%
3%
ROE
-22%
3%
1%
-1%
0%
7%
12%
1%
-4%
10%
ROCE
0%
7%
7%
8%
7%
11%
14%
9%
6%
11%
Fixed Asset Turnover
1.83
2.58
2.80
2.72
2.01
2.06
2.18
1.60
1.58
2.12
Receivable days
122
104
109
92
92
87
83
104
100
87
Inventory Days
147
110
105
75
70
65
64
92
85
81
Payable days
90
87
99
88
89
79
73
89
78
80
Cash Conversion Cycle
178
128
114
79
72
72
74
107
107
88
Total Debt/Equity
2.26
1.85
1.69
1.49
1.68
0.93
1.08
1.60
1.53
1.47
Interest Cover
0
1
1
1
1
2
2
1
1
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.